![Nirmala Bhoo Pathy: Creating a culture that values and supports peer reviewers ensures the continued integrity and progress of scientific research](https://oncodaily.com/pub/uploads/2023/11/1696284587433-e1705866224399.jpeg)
Nirmala Bhoo Pathy: Creating a culture that values and supports peer reviewers ensures the continued integrity and progress of scientific research
Nirmala Bhoo Pathy shared a post on LinkedIn:
“Creating a culture that values and supports peer reviewers ensures the continued integrity and progress of scientific research. This message from Mary (Nora) Disis of JAMA Oncology made my day.”
Source: Nirmala Bhoo Pathy/LinkedIn
Nirmala Bhoo-Pathy is as a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician in Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN). She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023